IRulya Therapeutics Inc. IRLA
39.80 USD +0.02 (+0.05%)
At closeNov 13, 2026, 4:00 PM EST
39.80 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
37.20 Day range 40.43
16.00 52-week range 880.00
- YTD
- -94.06%
- 1 year
- -88.15%
News
benzinga.com IRulya Therapeutics Q3 EPS $(2.31) Beats $(19.83) Estimate IRulya Therapeutics (NASDAQ:IRLA) reported quarterly losses of $(2.31) per share which beat the analyst consensus estimate of $(19.83) by 88.35 percent. This is a 95.36 percent increase over losses…
globenewswire.com IRulya Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results Name changed from Quince Therapeutics, Inc. to IRulya Therapeutics Inc.; common stock began trading on the Nasdaq Capital Market under the ticker “IRLA” on October 12, 2026 Phase 2 data in…
globenewswire.com IRulya Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) NEW HAVEN, Conn., Nov. 09, 2026 (GLOBE NEWSWIRE) -- IRulya Therapeutics Inc. (Nasdaq: IRLA), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Pharvaris (NASDAQ:PHVS) stock moved upwards by 19.4% to $36.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.0 billion. CalciMedica (NASDAQ:CALC)…